DDR on DTC: Vaniqa

Share this article:
DDR on DTC: Vaniqa
DDR on DTC: Vaniqa
Vaniqa is an Rx dermatological cream that reduces “unwanted facial hair” in women. It's a “cosmeceutical” brand that falls somewhere between the dermatologist's office and your local Sephora, and its new DTC campaign is just as confused. We see many happy customers in 60 seconds — all in close-up, too. They may be smiling because they got a $50 rebate, which is prominently displayed a few times.
The ad is very hard working. It uses a clinical tone so we know it's a serious, not frivolous, beauty aid. We see a brief “little science” demo that shows how hair follicle growth is stunted by an enzyme blocker in Vaniqa. And the ad delivers an end-benefit that could apply to any number of personal care products: “the freedom to be close to people.” All in all, it's basically a mini-infomercial, complete with testimonials and offers, but in a 60-second format
Unfortunately, even though a large amount of information is provided, the ad fails to build an emotional connection for the brand. And worse, the call-to-action is fumbled, so we are not sure what to do or where to go for this product. It's too bad the advertising misses an opportunity for Vaniqa to be memorable and wanted by the millions and millions of women who have “unwanted facial hair.” Ouch. My guess is that this is a large female target audience — one that other DTC cosmeceuticals such as Latisse and Oracea have figured out with effective, branded ads that convey both emotion and information.

Deborah Dick-Rath is SVP, healthcare practice leader, at FactorTG. Contact: deborah.dick-rath@factortg.com
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Headliner: Ipsen head leads continental charge

Headliner: Ipsen head leads continental charge

"When I look at the business, I actually see patients in my mind. I don't see numbers."

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets